![]() |
|||||||||||||||||||||
![]() |
|||||||||||||||||||||
![]() |
|
![]() |
|||||||||||||||||||
|
|||||||||||||||||||||
![]() |
Dr. Flockhart's research is focused on clinically-relevant applications of pharmacogenetics and drug interactions. He has been on the faculty in the Division of Clinical Pharmacology since 1993, and has been the Director of the Pharmacogenetics Core Laboratory, and Associate Director of the Division of Clinical Pharmacology since 1995. Dr Flockhart has more than 100 papers, reviews and abstracts in the area of pharmacology and clinical pharmacology, in which he specializes in the study of drug interactions and the contribution of genetics to inter-individual variations in drug response. He is a member of the American Board of Clinical Pharmacology and of the Executive Committee and Board of the American Society for Clinical Pharmacology and Experimental Therapeutics, where he serves as Chair of the Government Affairs Committee, Vice-Chair of the Pharmacokinetics and Drug Metabolism Section and Co-Chair of the Annual Formulary Training Workshop of the ASCPT for Pharmacy and Therapeutics Committees. Dr. Flockhart is an active teacher, and teaches the Clinical Pharmacogenetics portion of the annual course in Clinical Pharmacology at the National Institutes of Health, in Bethesda, MD and the Pharmacogenetics section of the Annual Review in Clinical Pharmacology provided by the ASCPT, as well as courses on drug metabolism and pharmacogenetics at Georgetown University Medical School and the Uniformed Services University for the Health Sciences. His website drug-interactions.com, a tool to improve rational prescribing, has been cited by the Washington Manual of Medicine and Therapeutics, The Helen Lane Handbook for Pediatrics and the Medical Letter, and receives approximately 1500 visits per month from scientists and physicians around the world. Return to Faculty Profile |
||||||||||||||||||||
|
|||||||||||||||||||||
The University of Arizona Center for Education and Research on Therapeutics Funded in part by Agency for Healthcare Research and Quality grant 1 U18 HS10385-01 Disclaimer and Waiver |